Rockwell Medical Inc. is a publicly traded (NASDAQ: RMTI) biopharmaceutical company founded in 1996 in Michigan. Rockwell focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD). This company performed top during ...
Improving patient outcomes with innovative drug therapies. Fully integrated bio pharmaceutical company targeting end-stage renal disease and chronic kidney disease. Their innovative drug Triferic is designed to prevent and treat iron deficiency anemia in end stage renal disease patients.
The Investor Relations website contains information about Rockwell Medical, Inc. 's business for stockholders, potential investors, and financial analysts.
Learn about working at Rockwell Medical, Inc.. Join LinkedIn today for free. See who you know at Rockwell Medical, Inc., leverage your professional network, and get hired.
Rockwell Medical Inc. stock price, stock quotes and financial overviews from MarketWatch.
View the basic RMTI stock chart on Yahoo Finance. Change the date range, chart type and compare Rockwell Medical, Inc. against other companies.
Rockwell Medical Technologies keeps on trucking with its hemodialysis products. The company makes hemodialysis concentrates (in liquid and dry powder form), dialysis kits, and other related products for treatment of end-stage renal disease ( chronic kidney failure). Subsidiary ... Read more ...
Rockwell Medical Inc. Stock - RMTI news, historical stock charts, analyst ratings, financials, and today's Rockwell Medical Inc. stock price.
Nov 26, 2017 ... Today we look at Rockwell Medical, which sports a $328M market cap on TTM GM$ of $6.9M that is trending down. The company is producing sales, but they are mostl.